Lupus, an autoimmune disorder, presents skin manifestations like the butterfly rash, often mimicked by conditions such as ...

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated statistically significant ...

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) as the first targeted therapy for bullous ...

Omalizumab yielded a high response rate and had an acceptable safety profile in children with chronic spontaneous urticaria (CSU), including those younger than 12 years, a meta-analysis showed.

Aquagenic urticaria is a rare condition in which water causes hives. Learn about its symptoms, causes, diagnosis, and treatment options.

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

Tacrolimus has previously shown antipruritic action in atopic dermatitis, so researchers decided to investigate it for uremic pruritus.

The study is intended to focus on diagnostics and treatment of Lyme IACI symptoms and not to improve diagnostics and treatment for acute Lyme disease. As such, the prevention of Lyme disease ...

No matter the treatment approach, it’s important to keep the area clean and dry, watch for signs of infection, and follow your doctor’s guidance closely. Umbilical Granulomas FAQs ...

According to long-term safety analyses of abrocitinib in moderate-to-severe atopic dermatitis, which of the following is a notable monitoring need?